Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Needle showdown: which therapy eases neck pain best?

NCT ID NCT07345793

Symptom relief Sponsor: Universidad Europea de Madrid Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested three needle-based treatments—dry needling, nerve stimulation, and electrolysis—on 60 people, first in healthy volunteers and then in those with chronic neck pain. Researchers measured pain and muscle stiffness right after treatment and again 24 hours later. The goal is to find out which technique works best for short-term relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dry needling, percutaneous nerve stimulation, and percutaneous electrolysis
What this could lead to
If successful, this could help refine which needle-based therapy works best for easing chronic neck pain in the short term.
What could go wrong
This is a small, early-stage study in healthy people and patients. Results may not apply to everyone, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2026

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA Phase 1 - healthy subjects 1. Age between 18 and 65 years. 2. Healthy individuals without any current musculoskeletal or neurological pathology. 3. Presence of a palpable myofascial trigger point in the upper trapezius muscle. 4. No neck or shoulder pain requiring medical treatment in the past three months. 5. Willingness to refrain from other physiotherapy or manual therapy interventions during the study period. 6. Ability to understand and provide written informed consent Phase 2 - Patients with Chronic Neck Pain 1. Age between 18 and 65 years. 2. Diagnosis of chronic mechanical or tension-type neck pain lasting for at least 3 months. 3. Presence of at least one active myofascial trigger point in the upper trapezius muscle. 4. Pain intensity between 3 and 7 on a 10-cm Visual Analog Scale (VAS) at baseline. 5. No previous invasive physiotherapy treatments (dry needling, electrolysis, or neuromodulation) within the last 4 weeks. 6. Ability and willingness to attend all study sessions and follow-up assessments. 7. Signed informed consent before participation. EXCLUSION CRITERIA 1. History of cervical or shoulder surgery. 2. Neurological, systemic, or rheumatologic disorders affecting the cervical or upper limb region. 3. Anticoagulant therapy or known bleeding disorders. 4. Pregnancy or suspected pregnancy. 5. Skin infection, wound, or dermatological condition at or near the intervention site. 6. Use of analgesic, anti-inflammatory, or muscle relaxant medications within 48 hours prior to the intervention. 7. Prior invasive physiotherapy (dry needling, PENS, or EPE) in the target area during the past month. 8. Contraindications to electrical stimulation (for PENS or EPE groups), such as implanted pacemaker or metal implants near the treatment area. 9. Fear of needles (trypanophobia) or intolerance to invasive procedures. 10. Participation in another clinical trial within the past 3 months. 11. Refusal or inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic neck pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic neck pain

Contacts and locations

Locations

  • Antonio Rejas Fisioterapia

    Cuenca, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.